Birgit Girshick Charles River Laboratories International, Inc. (CRL) insider trading activity

Birgit Girshick is Corporate Executive VP & COO of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 50,512 shares of CRL, which is worth approximately $10.1 Million. The most recent transaction as insider was on Feb 22, 2022, when has been sold 274 shares (Common Stock) at a price of $293.61 per share, resulting in proceeds of $80,449. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.5K

0% 3M change

13.64% 12M change

Total Value Held $10.1 Million

Birgit Girshick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2022	SELL Payment of exercise price or tax liability	$80,449 $293.61 p/Share	274 Reduced 0.8%	33,949 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$1,210,554 $312.24 p/Share	3,877 Reduced 10.18%	34,223 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	11,029 Added 22.45%	38,100 Common Stock
Sep 23 2021	SELL Bona fide gift	-	531 Reduced 1.92%	27,071 Common Stock
Sep 14 2021	SELL Open market or private sale	$1,031,126 $439.9 p/Share	2,344 Reduced 7.83%	27,602 Common Stock
Sep 13 2021	SELL Open market or private sale	$35,817 $442.18 p/Share	81 Reduced 0.27%	29,946 Common Stock
May 29 2021	SELL Payment of exercise price or tax liability	$73,006 $337.99 p/Share	216 Reduced 0.71%	30,027 Common Stock
May 28 2021	BUY Grant, award, or other acquisition	-	1,183 Added 3.76%	30,243 Common Stock
Apr 06 2021	SELL Open market or private sale	$5,540,359 $302.57 p/Share	18,311 Reduced 38.65%	29,060 Common Stock
Apr 06 2021	BUY Exercise of conversion of derivative security	$2,087,820 $114.02 p/Share	18,311 Added 34.36%	34,976 Common Stock
Apr 05 2021	SELL Open market or private sale	$297,702 $298.0 p/Share	999 Reduced 3.32%	29,060 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$87,962 $88.05 p/Share	999 Added 3.22%	30,059 Common Stock
Mar 01 2021	SELL Bona fide gift	-	350 Reduced 1.2%	28,710 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$91,120 $282.98 p/Share	322 Reduced 1.1%	29,060 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$89,331 $283.59 p/Share	315 Reduced 1.06%	29,382 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$89,181 $289.55 p/Share	308 Reduced 1.03%	29,697 Common Stock
Feb 19 2021	SELL Open market or private sale	$492,316 $293.92 p/Share	1,675 Reduced 5.29%	30,005 Common Stock
Feb 19 2021	BUY Exercise of conversion of derivative security	$123,447 $73.7 p/Share	1,675 Added 5.02%	31,680 Common Stock
Jan 29 2021	SELL Payment of exercise price or tax liability	$1,228,484 $260.88 p/Share	4,709 Reduced 13.57%	30,005 Common Stock
Jan 29 2021	BUY Grant, award, or other acquisition	-	11,862 Added 25.47%	34,714 Common Stock

Birgit Girshick

Corporate Executive VP & COO

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account